ANI
16 Sep 2020, 14:33 GMT+10
New Delhi [India], September 16 (ANI): The Supreme Court on Wednesday adjourned for two weeks hearing on a plea seeking registration of an FIR by the Central Bureau of Investigation (CBI) against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir, allegedly as medicines to treat COVID-19 patients, without valid licences.
A bench headed by Chief Justice SA Bobde told advocate ML Sharma, who has filed the plea, that there are rules framed by the Government of India for the new drugs and clinical trials.
"We are adjourning this matter you see the rule and come back," the bench said while adjourning the matter for two weeks.
Remdesivir and Favipiravir are antiviral drugs, however, their efficacy in treating COVID-19 patients has been a matter of debate among medical experts.
The plea alleged that the medicines are being manufactured and sold for treating COVID-19 patients without valid licences from the Central Drugs Standard Control Organisation.
Sharma, through his plea, sought prosecution of the Indian companies for cheating and criminal conspiracy besides under the provisions of the Drug Act, 1940 and said that these medicines have not been certified as medicines for COVID-19 till date by any country.
It said that the companies are manufacturing and selling them at very high rates in India and people are paying that due to the fear of COVID-19 infection and are dying.
It claimed that more than 300 doctors have died in hospitals where these two medicines have been supplied and it amounted to "exploitation of public due to the fear of death." (ANI)Get a daily dose of Manufacturing Mirror news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Manufacturing Mirror.
More InformationNew Delhi [India], July 2 (ANI): Union Minister of Communications Jyotiraditya Scindia slammed Congress President Mallikarjun Kharge...
Dehradun (Uttarakhand) [India], July 2 (ANI): Under the leadership of Chief Minister Pushkar Singh Dhami and Health Minister Dhan Singh...
New Delhi [India], July 1 (ANI): As the Digital India Mission completed 10 years on Tuesday, BJP leader Pradeep Bhandari drew contrast...
New Delhi [India], July 1 (ANI): Prime Minister Narendra Modi shared a blog titled 'A Decade of Digital India' on his official LinkedIn...
New Delhi [India], July 1 (ANI): Prime Minister Narendra Modi on Tuesday shared a detailed reflection on the completion of 10 years...
Jalalabad [ Afghanistan], June 30 (ANI/WAM): The UAE-funded maternity clinics are bringing hope to Afghan families. In Jalalabad, Nangarhar...
New Delhi [India], July 1 (ANI): Yard 12652 (Udaygiri), the second ship of Project 17A stealth frigate, being built at Mazagon Dock...
Mumbai (Maharashtra) [India], July 1 (ANI): Tata Motors reported total sales of 2,10,415 units in the first quarter of FY26, marking...
New Delhi [India], July 1 (ANI): Bajaj Auto Limited reported nearly flat total sales for June 2025 on a year-on-year basis, as gains...
Hong Kong, July 1 (ANI): China's harsh treatment of ethnic minorities, such as Muslim Uyghurs in the northwest province of Xinjiang,...
Mumbai (Maharashtra) [India], July 1 (ANI): In the automotive segment, Mahindra recorded total vehicle sales of 78,969 units, marking...
New Delhi [India], July 1 (ANI): The automobile industry in the country is expected to report mixed performance across segments for...